About
Technology
Issues
FAQ
Links
Official Page
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.